Sean Thompson, Co-Founder & CEO
Psigryph Inc. has acquired IP from the Paliyath Lab at the University of Guelph. The IP includes plant-derived nanostructures, methods of manufacture and food powders. The company filed patents in 2018 covering these technologies.
We have identified multiple potential product lines for our company including the food, pharmaceutical and cannabis industries that will benefit from our technologies. We can provide nutritional food ingredients and drug delivery technology for poorly soluble molecules to the pharma and cannabis industries. We also understand the obesity prevention potential of the food powder in animal studies that have shown chronic disease prevention potential. We see the food powder as our first product to be launched in 2020. We are also exploring the possibility of a cannabis edible product and nutrition bar to be launched in partnership with appropriate companies in 2020.